Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lola E. Navas
Observed names:
L. Eufemia Navas,
L. Navas,
Lola E Navas,
Lola Navas,
Navas, Lola,
Navas, Lola E.
show all 6
Institutions:
Consejo Superior de Investigaciones Científicas,
Instituto de Salud Carlos III,
Instituto de Biomedicina de Sevilla,
Hospital Universitario Virgen del Rocío,
Centro de Investigación Biomédica en Red de Cáncer,
Universidad de Sevilla
show all 6
Observed institutions:
Consejo Superior de Investigaciones Científicas,
Instituto de Salud Carlos III,
Centro de Investigación Biomédica en Red,
Instituto de Biomedicina de Sevilla,
Hospital Universitario Virgen del Rocío,
Centro de Investigación Biomédica en Red de Cáncer,
Universidad de Sevilla
show all 7
OpenAlex ID:
A5048243607
NAD+ metabolism, stemness, the immune response, and cancer
2020
·
Lola E. Navas
, Amancio Carnero
·
Signal Transduction and Targeted Therapy
·
518
Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
2022
·
Lola E. Navas
, Amancio Carnero
·
Cells
·
65
NAMPT as a Dedifferentiation-Inducer Gene: NAD+ as Core Axis for Glioma Cancer Stem-Like Cells Maintenance
2019
·
Antonio Lucena-Cacace
, Masayuki Umeda
, et al.
·
Frontiers in Oncology
·
43
New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools
2019
·
Sandra Muñoz-Galván
, Blanca Felipe-Abrio
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
39
PDF
Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer
2017
·
Eva M. Verdugo-Sivianes
, Lola Navas
, et al.
·
Oncotarget
·
17
NAD pool as an antitumor target against cancer stem cells in head and neck cancer
2023
·
Lola E. Navas
, Elena Blanco-Alcaina
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
16
PDF
Patient-derived xenografts as models for personalized medicine research in cancer
2016
·
Amancio Carnero
, Marco Perez
, et al.
·
Cancer translational medicine
·
4
Efficacy of NAMPT Inhibitors in Pancreatic Cancer After Stratification by MAP17 (PDZK1IP1) Levels
2025
·
Eva M. Verdugo-Sivianes
, Julia Martínez-Pérez
, et al.
·
Cancers
·
3
PDF
PO-106 Downregulation of MYPT increases tumorigenesis and resistance to platin drugs in ovarian cancer
2018
·
S. Muñoz-Galván
, B. Felipe-Abrio
, et al.
·
ESMO Open
·
1
PO-433 Prognostic relevance of PP1 in breast cancer
2018
·
E.M. Verdugo Sivianes
, B. Felipe Abrio
, et al.
·
ESMO Open
·
1
1655P Nampt inhibitors re-sensitize MAP17 expressing pancreas tumors
2023
·
J. Martinez Perez
, E.M. Verdugo Sivianes
, et al.
·
Annals of Oncology
PDF
P-10 Prognostic and predictive relevance of MAP17 in pancreatic cancer
2023
·
J. Martínez Pérez
, E. Verdugo Sivianes
, et al.
·
Annals of Oncology
PDF
Identification of a minimal biomarker profile in head-and-neck squamous cell carcinoma tumors
2021
·
Laura Sanchez-Diaz
, Lola E. Navas
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
PO-280 Hypoxia-induced PLD2 promotes tumorigenesis and stem cell-like properties in tumour cells
2018
·
D. Otero Albiol
, S. Munoz Galvan
, et al.
·
ESMO Open
Show more works
View as search
Works count:
18
Citation count:
706
H-index:
6
I10-index:
6
Year
Topic
Type